Healthcare Reports

Showing 7210–7218 of 13506 results

Default sorting Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 
  Healthcare Reports

  Metastatic Ovarian Cancer Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

• 
  Healthcare Reports

  Metastatic Pancreatic Cancer Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

• 
  Healthcare Reports

  Metastatic pancreatic ductal adenocarcinoma Market Size, Clinical Trials, Latest Developments, Demand and Growth Forecast 

  $4,299.00 – $5,999.00Price range: $4,299.00 through $5,999.00
• 
  Healthcare Reports

  Metastatic Prostate Cancer Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

• 
  Healthcare Reports

  Metastatic Renal Cell Carcinoma Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

• 
  Healthcare Reports

  Metastatic Transitional (Urothelial) Tract Cancer Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

• 
  Healthcare Reports

  Metastatic triple-negative breast cancer (mTNBC) Market Size, Clinical Trials, Latest Developments, Demand and Growth Forecast 

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00
• 
  Healthcare Reports

  Metastatic Uveal Melanoma Drugs – New Product Pipeline (Drugs Under Development), Market Analysis and Forecast

• 
  Healthcare Reports

  Metformin-based Combination Therapies for Prediabetes Market Size, Product Pipelines, Clinical Trials, Latest Developments, Demand and Growth Forecast 

  $4,299.00 – $8,499.00Price range: $4,299.00 through $8,499.00